To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene SMARCC2TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
383 representative clones for gene SMARCC2 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
NM_003075.3   .a 1 to 5588 1 to 5588 exact RefSeq,   5588/5588
(100 %)
0 diff
(100 %id)
U66616   .a 85 to 4110 1 to 4019 A311V K313E K314E N315K A316C ... tiling clone,   4019/4022
(99 %)
25 diff
(99.4 %id)
BC026222 Duodenum, adenocarcinoma .a 97 to 4095 16 to 4014 exact available from MGC, AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 3999/3999
(100 %)
2 diff
(100.0 %id)
AK315153 placenta .a 101 to 3751 1 to 3648 Q960P P963A A964L L965P P967G ... tiling clone,   3648/3648
(100 %)
3 diff
(100.0 %id)
BM477016 leiomyosarcoma, uterus .a 1005 to 1948 1 to 946       946/1080
(87 %)
23 diff
(97.9 %id)
BQ433125 embryonal carcinoma, cell line, testis .a 1039 to 1884 1 to 849       849/871
(97 %)
7 diff
(99.2 %id)
BQ925196 epidermoid carcinoma, cell line, lung .a 1179 to 1999 1 to 828       828/869
(95 %)
5 diff
(99.5 %id)
BQ949929 epidermoid carcinoma, cell line, lung .a 1179 to 2051 1 to 876       876/882
(99 %)
5 diff
(99.5 %id)
BP872488 embryonal kidney .a 1189 to 1773 1 to 585       585/587
(99 %)
2 diff
(99.7 %id)
AU128144   .a 1261 to 1798 2 to 540   capped   539/539
(100 %)
1 diff
(99.9 %id)
CD616227   .a 1284 to 2000 735 to 16       720/753
(95 %)
4 diff
(99.5 %id)
CD616226   .a 1285 to 1937 1 to 653       653/653
(100 %)
1 diff
(99.9 %id)
BU429394 lymph .a 1301 to 1850 1 to 550       550/550
(100 %)
5 diff
(99.1 %id)
BF972063 leiomyosarcoma cell line, uterus .a 1305 to 2156 1 to 844       844/905
(93 %)
15 diff
(98.4 %id)
BG338015 leiomyosarcoma cell line, uterus .a 1305 to 2154 1 to 849       849/1167
(72 %)
34 diff
(97.1 %id)
TI_154150443   .a 1306 to 1916 80 to 698       617/801
(77 %)
8 diff
(99.1 %id)
AU124211   .a 1313 to 2148 2 to 830   capped   829/859
(96 %)
15 diff
(98.3 %id)
CU454855 epidermis .a 1370 to 2154 21 to 805       785/805
(97 %)
0 diff
(100 %id)
BF929070 nervous_tumor .a 1371 to 1760 21 to 409       389/409
(95 %)
2 diff
(99.6 %id)
BG327007 Kidney, renal cell adenocarcinoma .a 1436 to 2177 1 to 737       737/739
(99 %)
10 diff
(98.7 %id)
DA061280 cerebellum .a 1500 to 2066 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
AW362845 colon .a 1502 to 1979 478 to 3       476/501
(95 %)
3 diff
(99.5 %id)
DA486598 brain .a 1509 to 2069 2 to 562   capped   561/561
(100 %)
1 diff
(99.9 %id)
AW247650 lung, small cell carcinoma .a 1531 to 2006 6 to 481       476/481
(98 %)
0 diff
(100 %id)
DB122780 thymus .a 1548 to 2142 2 to 596   capped   595/595
(100 %)
1 diff
(99.9 %id)
AI928660 anaplastic oligodendroglioma, brain .a 1580 to 1854 275 to 1       275/278
(98 %)
2 diff
(99.3 %id)
BQ323825 colon_ins .a 1597 to 1958 1 to 364       364/364
(100 %)
14 diff
(96.2 %id)
BI161286 epithelioid carcinoma cell line, Pancreas .a 1607 to 2295 1 to 705       705/873
(80 %)
28 diff
(96.8 %id)
BU197166 ductal carcinoma, cell line, Pancreas .a 1620 to 2365 1 to 747       747/918
(81 %)
7 diff
(99.3 %id)
BQ685603 ductal carcinoma, cell line, Pancreas .a 1620 to 2426 1 to 807       807/842
(95 %)
5 diff
(99.5 %id)
BQ438906 embryonal carcinoma, cell line, testis .a 1629 to 2532 1 to 904       904/904
(100 %)
18 diff
(98.1 %id)
DB122886 thymus .a 1633 to 2198 2 to 567   capped   566/567
(99 %)
2 diff
(99.7 %id)
BE293316 adenocarcinoma cell line, colon .a 1635 to 2184 1 to 550       550/550
(100 %)
0 diff
(100 %id)
BQ279134 adenocarcinoma, cell line, breast .a 1655 to 2493 1 to 842       842/957
(87 %)
11 diff
(98.9 %id)
DA921842 small intestine .a 1682 to 2256 2 to 576   capped   575/575
(100 %)
0 diff
(100 %id)
BF751176 breast_normal .a 1704 to 2035 38 to 368       331/368
(89 %)
2 diff
(99.5 %id)
BU186524 large cell carcinoma, lung .a 1717 to 2556 1 to 845       845/874
(96 %)
13 diff
(98.6 %id)
AL047315 uterus .a 1720 to 2272 1 to 553       553/553
(100 %)
0 diff
(100 %id)
BF983861 duodenal adenocarcinoma, cell line, small intestine .a 1729 to 2360 1 to 632       632/632
(100 %)
0 diff
(100 %id)
AU141252 thyroid gland .a 2014 to 2714 2 to 702   capped   701/703
(99 %)
4 diff
(99.5 %id)
BC009067 Colon, adenocarcinoma .a 2353 to 4095 1 to 1743   tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 1743/1743
(100 %)
0 diff
(100 %id)
BC128599 PCR rescued clones, C list .a 2426 to 3384 959 to 1     Submitted on the opposite strand 959/969
(98 %)
3 diff
(99.7 %id)
BQ942636 large cell carcinoma, lung .a 2507 to 3398 1 to 907       907/914
(99 %)
21 diff
(97.8 %id)
BM917329 blood, natural killer cells, cell line .a 2524 to 3403 1 to 886       886/1026
(86 %)
10 diff
(99.1 %id)
BQ052036 blood, natural killer cells, cell line .a 2524 to 3513 1 to 1007       1007/1089
(92 %)
42 diff
(96.2 %id)
BQ052610 blood, natural killer cells, cell line .a 2524 to 3460 1 to 955       955/1032
(92 %)
42 diff
(96.0 %id)
BM561395 blood, natural killer cells, cell line .a 2575 to 3544 1 to 977       977/977
(100 %)
21 diff
(97.9 %id)
CR991052 T-Lymphocytes .a 2635 to 3446 1 to 811       811/812
(99 %)
4 diff
(99.6 %id)
CR983474 T-Lymphocytes .a 2672 to 3402 1 to 733       733/733
(100 %)
5 diff
(99.4 %id)
BU167005 melanotic melanoma, skin .a 2755 to 3507 1 to 768       768/819
(93 %)
25 diff
(97.0 %id)
DA371088 thalamus .a 2793 to 3367 2 to 577   capped   576/576
(100 %)
1 diff
(99.9 %id)
BM555038 amelanotic melanoma, cell line, skin .a 2833 to 3592 25 to 790       766/1107
(69 %)
17 diff
(98.5 %id)
BM554649 amelanotic melanoma, cell line, skin .a 2833 to 3759 1 to 934       934/997
(93 %)
16 diff
(98.4 %id)
BM423624 amelanotic melanoma, cell line, skin .a 2833 to 3788 1 to 966       966/1018
(94 %)
27 diff
(97.4 %id)
BM810302 amelanotic melanoma, cell line, skin .a 2834 to 3852 1 to 1017       1017/1117
(91 %)
58 diff
(94.9 %id)
BM911735 amelanotic melanoma, cell line, skin .a 2834 to 3601 1 to 772       772/998
(77 %)
22 diff
(97.8 %id)
BM913116 amelanotic melanoma, cell line, skin .a 2834 to 3557 1 to 724       724/1042
(69 %)
15 diff
(98.6 %id)
BQ917727 large cell carcinoma, lung .a 2855 to 3732 1 to 888       888/894
(99 %)
17 diff
(98.1 %id)
BG120133 adenocarcinoma, cell line, Liver .a 2864 to 3590 13 to 731       718/957
(75 %)
43 diff
(95.6 %id)
DA982885 synovial membrane tissue from rheumatioidarthritis .a 2874 to 3367 2 to 495   capped   494/494
(100 %)
0 diff
(100 %id)
BM541497 leiomyosarcoma, uterus .a 3030 to 4029 1 to 1001       1001/1005
(99 %)
17 diff
(98.4 %id)
CB851281 lung, Primary Lung Epithelial Cells .a 3126 to 3849 1 to 723     Submitted on the opposite strand 723/723
(100 %)
8 diff
(98.9 %id)
T53596 placenta .a 3146 to 3369 1 to 223       223/223
(100 %)
7 diff
(96.9 %id)
BQ642878 lymph, lymphoma, cell line .a 3158 to 4069 1 to 912       912/917
(99 %)
8 diff
(99.2 %id)
BQ060793 lymph, lymphoma, cell line .a 3194 to 4112 1 to 927       927/1036
(89 %)
14 diff
(98.7 %id)
BP431742   .a 3243 to 3626 1 to 384       384/384
(100 %)
2 diff
(99.5 %id)
R73206 breast .a 3254 to 3601 1 to 347       347/347
(100 %)
6 diff
(98.3 %id)
BG149350 carcinoid, lung .a 3257 to 3771 1 to 527     Submitted on the opposite strand 527/527
(100 %)
32 diff
(94.0 %id)
AA346412 heart .a 3269 to 3524 1 to 256       256/256
(100 %)
1 diff
(99.7 %id)
AW950766   .a 3270 to 3849 1 to 583       583/641
(90 %)
16 diff
(97.6 %id)
DA430098 colon .a 3281 to 3834 2 to 555   capped   554/554
(100 %)
0 diff
(100 %id)
CA774490 Pancreas, Purified pancreatic islet .a 3290 to 4096 806 to 1       806/806
(100 %)
14 diff
(98.3 %id)
BQ643795 hepatocellular carcinoma, cell line, Liver .a 3311 to 4112 22 to 839       818/1016
(80 %)
51 diff
(95.0 %id)
BQ645836 hepatocellular carcinoma, cell line, Liver .a 3312 to 4095 1 to 784   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 784/784
(100 %)
2 diff
(99.8 %id)
BM706186 eye, lens .a 3322 to 3819 1 to 494       494/508
(97 %)
5 diff
(99.1 %id)
TI_227715259   .a 3329 to 4119 852 to 65       788/1073
(73 %)
19 diff
(98.3 %id)
AI081240 B-cell, chronic lymphotic leukemia .a 3344 to 4096 752 to 1       752/752
(100 %)
23 diff
(97.0 %id)
AA345080 gall bladder .a 3381 to 3699 1 to 320       320/320
(100 %)
4 diff
(98.8 %id)
TI_149281847   .a 3386 to 4112 794 to 68   tiling clone,   727/795
(91 %)
2 diff
(99.8 %id)
BP431565   .a 3387 to 3721 1 to 335       335/335
(100 %)
4 diff
(98.9 %id)
BM983546 lung .a 3406 to 4095 708 to 19   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 690/690
(100 %)
2 diff
(99.8 %id)
BE348512 carcinoid, lung .a 3408 to 3849 1 to 441     Submitted on the opposite strand 441/441
(100 %)
6 diff
(98.7 %id)
BF684296 leiomyosarcoma cell line, uterus .a 3412 to 4113 1 to 707   tiling clone,   707/774
(91 %)
26 diff
(96.7 %id)
BG338696 leiomyosarcoma cell line, uterus .a 3412 to 4054 1 to 645       645/966
(66 %)
17 diff
(98.3 %id)
AA368292 placenta .a 3426 to 3580 1 to 155       155/155
(100 %)
0 diff
(100 %id)
CA848663 Pancreas, Purified pancreatic islet .a 3435 to 3977 7 to 549       543/549
(98 %)
0 diff
(100 %id)
CD365740 Alveolar Macrophage, lung .a 3440 to 4095 675 to 19   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 657/657
(100 %)
1 diff
(99.9 %id)
AW404599 lymph .a 3452 to 3740 1 to 289       289/289
(100 %)
5 diff
(98.3 %id)
BU736948 eye, lens .a 3453 to 4095 661 to 19   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 643/643
(100 %)
0 diff
(100 %id)
BG231920 blood, lymphocyte .a 3515 to 4094 580 to 1       580/580
(100 %)
4 diff
(99.4 %id)
BQ128131 insulinoma, Pancreas .a 3519 to 4111 592 to 1       592/593
(99 %)
3 diff
(99.5 %id)
CK905729 insulinoma, Pancreas .a 3519 to 4111 592 to 1       592/599
(98 %)
2 diff
(99.7 %id)
AU158873 thyroid gland .a 3528 to 4095 566 to 1       566/578
(97 %)
23 diff
(96.1 %id)
BU629530 cell lines, Chondrosarcoma .a 3545 to 4095 570 to 19   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 552/552
(100 %)
3 diff
(99.5 %id)
BF448301 carcinoid, lung .a 3565 to 4050 8 to 493     Submitted on the opposite strand 486/493
(98 %)
0 diff
(100 %id)
BE218565 carcinoid, lung .a 3578 to 4021 1 to 444     Submitted on the opposite strand 444/444
(100 %)
0 diff
(100 %id)
BP429163   .a 3583 to 3882 1 to 300       300/300
(100 %)
2 diff
(99.4 %id)
AA931801 carcinoid, lung .a 3599 to 3995 1 to 398     Submitted on the opposite strand 398/398
(100 %)
3 diff
(99.3 %id)
BE465335 carcinoid, lung .a 3599 to 4095 1 to 497   AAA Submitted on the opposite strand 497/497
(100 %)
0 diff
(100 %id)
AB209006 brain .b 1 to 4271 1 to 4271 exact tiling clone,   4271/4271
(100 %)
0 diff
(100 %id)
NM_001130420.1   .b 1 to 5402 1 to 5402 exact RefSeq,   5402/5402
(100 %)
0 diff
(100 %id)
DA911917   .b 54 to 617 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
DA111750 cerebellum .b 61 to 635 2 to 576   capped   575/575
(100 %)
0 diff
(100 %id)
DA186006 amygdala .b 65 to 597 2 to 534   capped   533/533
(100 %)
0 diff
(100 %id)
DB129414 thymus .b 65 to 592 2 to 529   capped   528/528
(100 %)
0 diff
(100 %id)
DB164404 thymus .b 65 to 635 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
DB000913 breast, tumor tissue .b 66 to 596 2 to 532   capped   531/531
(100 %)
0 diff
(100 %id)
DA333559 hippocampus .b 71 to 646 2 to 577   capped   576/576
(100 %)
0 diff
(100 %id)
BU521163 leiomyosarcoma, uterus .b 74 to 935 9 to 870       862/870
(99 %)
4 diff
(99.6 %id)
DA494392 brain .b 77 to 620 2 to 545   capped   544/544
(100 %)
0 diff
(100 %id)
CR994201 T-Lymphocytes .b 80 to 912 1 to 834       834/837
(99 %)
4 diff
(99.6 %id)
CT003174 T-Lymphocytes .b 80 to 907 1 to 830       830/833
(99 %)
4 diff
(99.6 %id)
AL041177 testis .b 83 to 476 1 to 394       394/394
(100 %)
0 diff
(100 %id)
DA772405 brain .b 83 to 639 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
DA786064 brain .b 83 to 629 2 to 548   capped   547/547
(100 %)
0 diff
(100 %id)
DA808278 brain .b 83 to 656 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
DA456202 tongue, tumor tissue .b 86 to 641 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
DA508887 brain .b 86 to 643 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
AL544435 placenta, Placenta Cot 25-normalized .b 87 to 1047 1 to 957       957/957
(100 %)
8 diff
(99.2 %id)
BQ438093 melanotic melanoma, skin .b 90 to 812 1 to 725       725/871
(83 %)
6 diff
(99.4 %id)
DA324548 hippocampus .b 95 to 629 2 to 536   capped   535/535
(100 %)
0 diff
(100 %id)
DA402062 thalamus .b 95 to 658 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
DB085438 testis .b 95 to 653 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
DA107709 cerebellum .b 96 to 628 2 to 534   capped   533/533
(100 %)
0 diff
(100 %id)
DA127368 cerebellum .b 96 to 674 2 to 580   capped   579/579
(100 %)
0 diff
(100 %id)
DA180923 amygdala .b 96 to 643 2 to 549   capped   548/548
(100 %)
0 diff
(100 %id)
DA232673 brain .b 96 to 658 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
DA234811 brain .b 96 to 697 2 to 603   capped   602/602
(100 %)
0 diff
(100 %id)
DA315799 hippocampus .b 96 to 646 2 to 552   capped   551/551
(100 %)
0 diff
(100 %id)
DA337273 hippocampus .b 96 to 671 2 to 577   capped   576/576
(100 %)
0 diff
(100 %id)
DA388783 thalamus .b 96 to 696 2 to 602   capped   601/601
(100 %)
0 diff
(100 %id)
DA398888 thalamus .b 96 to 662 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
DA402385 thalamus .b 96 to 643 2 to 549   capped   548/548
(100 %)
0 diff
(100 %id)
DA402931 thalamus .b 96 to 690 2 to 596   capped   595/595
(100 %)
0 diff
(100 %id)
DA407878 thalamus .b 96 to 650 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
DA411219 thalamus .b 96 to 738 2 to 644   capped   643/651
(98 %)
0 diff
(100 %id)
DA458709 tongue, tumor tissue .b 96 to 556 2 to 462   capped   461/461
(100 %)
0 diff
(100 %id)
DA489313 brain .b 96 to 629 2 to 535   capped   534/534
(100 %)
0 diff
(100 %id)
DA499656 brain .b 96 to 648 2 to 554   capped   553/553
(100 %)
0 diff
(100 %id)
DA508131 brain .b 96 to 629 2 to 535   capped   534/534
(100 %)
0 diff
(100 %id)
DA556609   .b 96 to 656 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
DA722377   .b 96 to 665 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
DA725335   .b 96 to 648 2 to 554   capped   553/553
(100 %)
0 diff
(100 %id)
DA725379   .b 96 to 648 2 to 554   capped   553/553
(100 %)
0 diff
(100 %id)
DA800656 brain .b 96 to 640 2 to 546   capped   545/545
(100 %)
0 diff
(100 %id)
DA801091 brain .b 96 to 647 2 to 553   capped   552/552
(100 %)
0 diff
(100 %id)
DA857702 placenta .b 96 to 640 2 to 546   capped   545/545
(100 %)
0 diff
(100 %id)
DA859681 placenta .b 96 to 651 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
DB153707 thymus .b 96 to 666 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
AU141662 thyroid gland .b 96 to 935 2 to 843   capped   842/842
(100 %)
7 diff
(99.2 %id)
DB232219 trachea .b 96 to 694 2 to 600   capped   599/599
(100 %)
0 diff
(100 %id)
DB232252 trachea .b 96 to 433 2 to 339   capped   338/338
(100 %)
0 diff
(100 %id)
DB278007 uterus .b 96 to 612 2 to 518   capped   517/517
(100 %)
0 diff
(100 %id)
DB285817 uterus .b 96 to 635 2 to 541   capped   540/540
(100 %)
0 diff
(100 %id)
DA188218 amygdala .b 97 to 629 2 to 534   capped   533/533
(100 %)
0 diff
(100 %id)
BI819265 pooled brain, lung, testis .b 99 to 907 1 to 819       819/820
(99 %)
17 diff
(98.0 %id)
DA183949 amygdala .b 101 to 612 2 to 513   capped   512/512
(100 %)
0 diff
(100 %id)
DA312100 hippocampus .b 101 to 632 2 to 533   capped   532/532
(100 %)
0 diff
(100 %id)
DA338099 hippocampus .b 101 to 694 2 to 595   capped   594/594
(100 %)
0 diff
(100 %id)
DA459846 tongue, tumor tissue .b 101 to 671 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
DA858998 placenta .b 102 to 677 2 to 577   capped   576/576
(100 %)
0 diff
(100 %id)
DA187785 amygdala .b 104 to 649 2 to 547   capped   546/546
(100 %)
0 diff
(100 %id)
DA233009 brain .b 104 to 657 2 to 555   capped   554/554
(100 %)
0 diff
(100 %id)
DA437869 tongue, tumor tissue .b 104 to 662 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
DA774512 brain .b 104 to 668 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
EL733177 mixed .b 107 to 816 1 to 706       706/736
(95 %)
6 diff
(99.2 %id)
BQ890066 brain, neuroblastoma, cell line .b 110 to 984 1 to 878       878/918
(95 %)
5 diff
(99.5 %id)
CR994189 T-Lymphocytes .b 113 to 746 1 to 634       634/634
(100 %)
0 diff
(100 %id)
BU931252 ovary, teratocarcinoma, cell line .b 114 to 957 1 to 852       852/907
(93 %)
33 diff
(96.4 %id)
BQ050514 leiomyosarcoma, uterus .b 117 to 957 1 to 845       845/1029
(82 %)
14 diff
(98.7 %id)
BU844536 ovary, teratocarcinoma, cell line .b 118 to 945 1 to 838       838/877
(95 %)
16 diff
(98.2 %id)
TI_154164042   .b 128 to 1024 77 to 961       885/937
(94 %)
30 diff
(96.8 %id)
CN349298 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 145 to 878 1 to 736       736/736
(100 %)
3 diff
(99.6 %id)
DA110663 cerebellum .b 170 to 728 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
AA767233 germinal center B cell .b 217 to 1044 831 to 3       829/918
(90 %)
27 diff
(97.1 %id)
DA160990 amygdala .b 218 to 789 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
DA517351 brain .b 268 to 828 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
DA810915 brain .b 327 to 809 2 to 484   capped   483/483
(100 %)
0 diff
(100 %id)
CD516819 White Matter .b 393 to 1253 1 to 866       866/879
(98 %)
13 diff
(98.6 %id)
BU166308 melanotic melanoma, skin .b 426 to 1260 12 to 846       833/846
(98 %)
3 diff
(99.7 %id)
BQ345157 nervous_tumor .b 456 to 896 445 to 6       440/445
(98 %)
3 diff
(99.4 %id)
DA240210 brain .b 474 to 1018 2 to 546   capped   545/545
(100 %)
0 diff
(100 %id)
AI017576 pooled .b 479 to 1039 561 to 1       561/561
(100 %)
0 diff
(100 %id)
BF931285 nervous_tumor .b 510 to 903 394 to 1     Submitted on the opposite strand 394/394
(100 %)
4 diff
(99.0 %id)
DA739575   .b 533 to 1048 2 to 517   capped   516/516
(100 %)
0 diff
(100 %id)
DA776955 brain .b 533 to 1109 2 to 578   capped   577/577
(100 %)
0 diff
(100 %id)
DA788764 brain .b 533 to 1018 2 to 487   capped   486/486
(100 %)
0 diff
(100 %id)
DA804780 brain .b 533 to 1093 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
DA999045 breast, tumor tissue .b 533 to 1100 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
DA121074 cerebellum .b 535 to 1073 2 to 540   capped   539/539
(100 %)
0 diff
(100 %id)
DB160401 thymus .b 535 to 1126 2 to 593   capped   592/592
(100 %)
0 diff
(100 %id)
DA803663 brain .b 561 to 1123 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
DA246621 brain .b 603 to 1181 2 to 580   capped   579/579
(100 %)
0 diff
(100 %id)
DB218795 trachea .b 624 to 1125 2 to 503   capped   502/502
(100 %)
0 diff
(100 %id)
CN349292 embryonic stem cells, cell lines H1, H7, andH9 .b 625 to 1309 1 to 685       685/687
(99 %)
4 diff
(99.5 %id)
BE929920 placenta_normal .b 630 to 810 208 to 26       183/214
(85 %)
2 diff
(99.1 %id)
BF087034 head_neck .b 681 to 866 208 to 23       186/219
(84 %)
2 diff
(99.1 %id)
BQ344984 nervous_tumor .b 724 to 1036 339 to 28       312/339
(92 %)
3 diff
(99.2 %id)
BQ949071 epidermoid carcinoma, cell line, lung .b 782 to 1680 1 to 903       903/909
(99 %)
6 diff
(99.4 %id)
BI040755 nervous_tumor .b 824 to 1255 445 to 7       439/445
(98 %)
18 diff
(96.0 %id)
GD156775   .b 825 to 1041 852 to 1081   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 230/1088
(21 %)
3 diff
(99.8 %id)
BQ638557 eye, retina .b 838 to 1452 1 to 615       615/615
(100 %)
0 diff
(100 %id)
BX327768 Placenta Cot 25-normalized .b 880 to 1753 1 to 868       868/925
(93 %)
25 diff
(97.3 %id)
DA802225 brain .b 896 to 1450 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
DA503790 brain .b 963 to 1509 2 to 548   capped   547/547
(100 %)
0 diff
(100 %id)
AW268078 invasive adenocarcinoma, lung .b 978 to 1036 12 to 70     Submitted on the opposite strand 59/70
(84 %)
0 diff
(100 %id)
DB137582 thymus .b 1003 to 1558 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
DA774218 brain .b 1042 to 1629 2 to 589   capped   588/588
(100 %)
0 diff
(100 %id)
DA690717   .b 1043 to 1603 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
AI940408 colon .b 1063 to 1258 208 to 4       205/229
(89 %)
13 diff
(94.4 %id)
FN075486 breast carcinoma .b 1073 to 1177 109 to 2     Submitted on the opposite strand 108/109
(99 %)
0 diff
(100 %id)
DB158702 thymus .b 1081 to 1668 2 to 589   capped   588/588
(100 %)
0 diff
(100 %id)
DA201371 brain .b 1089 to 1614 2 to 527   capped   526/526
(100 %)
0 diff
(100 %id)
DB126817 thymus .b 1106 to 1672 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
BG576320 breast, mammary adenocarcinoma, cell line .b 1173 to 1845 1 to 673       673/675
(99 %)
1 diff
(99.9 %id)
DA817299   .b 1182 to 1741 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
DA081765 cerebellum .b 1394 to 1959 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
DA081772 cerebellum .b 1394 to 1948 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
DA387132 thalamus .b 1399 to 1984 2 to 587   capped   586/586
(100 %)
0 diff
(100 %id)
BF436598 breast, invasive ductal carcinoma, 3 pooled samples .b 1445 to 1947 503 to 1       503/503
(100 %)
0 diff
(100 %id)
CB134373 brain .b 1555 to 2133 1 to 579       579/579
(100 %)
0 diff
(100 %id)
DA768316 brain .b 1634 to 2154 2 to 522   capped   521/521
(100 %)
0 diff
(100 %id)
CA389356 eye, RPE/choroid .b 1869 to 2469 1 to 601       601/601
(100 %)
0 diff
(100 %id)
DA254876 caudate nucleus .b 1871 to 2435 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
DA960116 Spleen .b 1907 to 2459 2 to 554   capped   553/553
(100 %)
0 diff
(100 %id)
DA622928 Kidney .b 1909 to 2491 2 to 584   capped   583/583
(100 %)
0 diff
(100 %id)
CR981629 T-Lymphocytes .b 1946 to 2809 1 to 865       865/875
(98 %)
9 diff
(99.0 %id)
DA819338   .b 1949 to 2513 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
DA599955   .b 1956 to 2509 2 to 555   capped   554/554
(100 %)
0 diff
(100 %id)
BM709274 eye, optic nerve .b 1974 to 2505 1 to 532     Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 532/532
(100 %)
0 diff
(100 %id)
DA603221   .b 1996 to 2555 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
DA948801 Spleen .b 1996 to 2533 2 to 539   capped   538/538
(100 %)
0 diff
(100 %id)
BM474277 leiomyosarcoma, uterus .b 2078 to 3037 13 to 981       969/999
(96 %)
12 diff
(98.8 %id)
CR983210 T-Lymphocytes .b 2102 to 2814 1 to 713       713/713
(100 %)
2 diff
(99.8 %id)
BM917177 blood, natural killer cells, cell line .b 2106 to 2970 1 to 870       870/1087
(80 %)
12 diff
(98.9 %id)
BQ712252 Spleen .b 2143 to 2970 1 to 836       836/953
(87 %)
20 diff
(98.0 %id)
BQ925319 large cell carcinoma, lung .b 2157 to 3027 1 to 882       879/885
(99 %)
19 diff
(97.9 %id)
Z78393 brain .b 2193 to 3221 1 to 1031       1031/1031
(100 %)
19 diff
(98.2 %id)
CN298750 embryonic stem cells, DMSO-treated H9 cellline .b 2212 to 2839 1 to 628       628/628
(100 %)
0 diff
(100 %id)
BX371584 Placenta Cot 25-normalized .b 2214 to 3087 869 to 1       869/869
(100 %)
12 diff
(98.7 %id)
BE298828 muscle, rhabdomyosarcoma .b 2226 to 2549 1 to 324       324/324
(100 %)
0 diff
(100 %id)
BX371585 Placenta Cot 25-normalized .b 2230 to 3087 844 to 1       846/846
(100 %)
35 diff
(95.9 %id)
BM800370 leiomyosarcoma, uterus .b 2237 to 3148 1 to 917       917/1056
(86 %)
31 diff
(97.1 %id)
BE266698 lung, small cell carcinoma .b 2283 to 2549 1 to 267       267/267
(100 %)
0 diff
(100 %id)
CN298749 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 2312 to 2955 1 to 644       644/644
(100 %)
0 diff
(100 %id)
BQ051569 blood, natural killer cells, cell line .b 2327 to 3327 1 to 1005       1005/1035
(97 %)
24 diff
(97.7 %id)
BU166391 melanotic melanoma, cell line, skin .b 2374 to 3144 1 to 775       775/863
(89 %)
12 diff
(98.7 %id)
BQ677507 melanotic melanoma, cell line, skin .b 2374 to 3227 1 to 868       868/907
(95 %)
26 diff
(97.2 %id)
CD515531 White Matter .b 2431 to 3324 27 to 925       899/925
(97 %)
6 diff
(99.4 %id)
BU500527   .b 2456 to 3379 9 to 938       928/938
(98 %)
9 diff
(99.1 %id)
CN298752 embryonic stem cells, DMSO-treated H9 cellline .b 2526 to 3085 1 to 560       560/560
(100 %)
0 diff
(100 %id)
BQ642170 lymph, lymphoma, cell line .b 2638 to 3429 1 to 799       796/938
(84 %)
13 diff
(98.7 %id)
BU947475 insulinoma, Pancreas .b 2677 to 3105 8 to 436     Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 429/436
(98 %)
0 diff
(100 %id)
BM708157 eye, RPE and Choroid .b 2954 to 3373 1 to 420   fully sequenced, Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 420/420
(100 %)
0 diff
(100 %id)
CA774622 Pancreas, Purified pancreatic islet .b 3125 to 3910 786 to 1       786/786
(100 %)
7 diff
(99.2 %id)
BU732423 eye, optic nerve .b 3320 to 3909 607 to 19   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 589/589
(100 %)
0 diff
(100 %id)
BU732005 eye, RPE and Choroid .b 3343 to 3909 586 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 568/568
(100 %)
1 diff
(99.9 %id)
AA989325 carcinoid, lung .b 3398 to 3807 1 to 410     Submitted on the opposite strand 410/410
(100 %)
0 diff
(100 %id)
BU786265 insulinoma, Pancreas .b 3553 to 3909 377 to 21   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 357/357
(100 %)
0 diff
(100 %id)
TI_227713670   .b 3970 to 4888 993 to 87   tiling clone, AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 907/1004
(90 %)
23 diff
(97.8 %id)
BM695396 eye, optic nerve .b 4007 to 4297 1 to 291   fully sequenced, Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 291/291
(100 %)
2 diff
(99.4 %id)
BE899111 adenocarcinoma cell line, ovary .b 4018 to 4855 1 to 822       822/833
(98 %)
25 diff
(97.0 %id)
TI_159722539   .b 4028 to 4888 930 to 79   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 852/1015
(83 %)
23 diff
(97.8 %id)
BQ278637 adenocarcinoma, cell line, breast .b 4048 to 4887 1 to 842   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 842/844
(99 %)
6 diff
(99.3 %id)
BU539423 adenocarcinoma, cell line, breast .b 4048 to 4888 1 to 847   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 847/847
(100 %)
7 diff
(99.2 %id)
TI_149298744   .b 4061 to 4888 909 to 87   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 823/961
(85 %)
14 diff
(98.6 %id)
BQ221092 large cell carcinoma, lung .b 4097 to 4880 1 to 790       790/923
(85 %)
16 diff
(98.3 %id)
BG576857 breast, mammary adenocarcinoma, cell line .b 4130 to 4797 1 to 668       668/668
(100 %)
0 diff
(100 %id)
BQ962209 epithelioid carcinoma cell line, Pancreas .b 4136 to 4888 1 to 752   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 752/752
(100 %)
2 diff
(99.8 %id)
TI_149294021   .b 4144 to 4888 828 to 89   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 740/760
(97 %)
5 diff
(99.4 %id)
CA427888 Bone, Subchondral Bone .b 4152 to 4888 753 to 19   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 735/736
(99 %)
3 diff
(99.6 %id)
BU682936 lung .b 4182 to 4888 723 to 19   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 705/705
(100 %)
2 diff
(99.8 %id)
CB850719 lung, Primary Lung Cystic Fibrosis EpithelialCells .b 4182 to 4888 725 to 19   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 707/707
(100 %)
0 diff
(100 %id)
CD742680 Alveolar Macrophage, lung .b 4203 to 4888 704 to 19   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 686/686
(100 %)
0 diff
(100 %id)
BQ187253 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .b 4254 to 4895 1 to 643   tiling clone, fully sequenced, Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 643/643
(100 %)
4 diff
(99.4 %id)
BM665041 eye, optic nerve .b 4267 to 4888 641 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 623/623
(100 %)
1 diff
(99.9 %id)
CK300581 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .b 4292 to 4894 622 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 604/604
(100 %)
1 diff
(99.9 %id)
BE222490 carcinoid, lung .b 4368 to 4887 520 to 1       520/520
(100 %)
0 diff
(100 %id)
BM875330 insulinoma, Pancreas .b 4400 to 4894 514 to 20   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 495/495
(100 %)
0 diff
(100 %id)
BX476347   .b 4426 to 4881 1 to 456       456/456
(100 %)
0 diff
(100 %id)
AI083535 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 4470 to 4894 425 to 1       425/425
(100 %)
0 diff
(100 %id)
AI632507 pooled germ cell tumors .b 4474 to 4888 415 to 1       415/415
(100 %)
0 diff
(100 %id)
AW273176 serous papillary carcinoma, high grade, 2pooled tumors, uterus .b 4483 to 4893 411 to 1       411/411
(100 %)
0 diff
(100 %id)
AI631215 Kidney, renal cell tumor .b 4547 to 4888 342 to 1       342/342
(100 %)
0 diff
(100 %id)
AA740839 germinal center B cell .b 4661 to 4893 243 to 11   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 233/233
(100 %)
0 diff
(100 %id)
AB209293 brain .c 1 to 3812 4 to 3815 exact tiling clone,   3815/3815
(100 %)
1 diff
(100.0 %id)
BQ071171 brain, neuroblastoma, cell line .c 1010 to 1936 1 to 935       935/982
(95 %)
17 diff
(98.3 %id)
NM_139067.2   .d 1 to 5336 1 to 5336 exact RefSeq,   5336/5336
(100 %)
0 diff
(100 %id)
BC013045 Brain, anaplastic oligodendroglioma with1p/19q loss .d 75 to 3843 1 to 3769 L907F tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 3769/3769
(100 %)
1 diff
(100.0 %id)
BT009924   .d 107 to 3497 1 to 3391       3391/3393
(99 %)
2 diff
(100.0 %id)
AU130983   .d 1048 to 1723 2 to 676   capped   675/675
(100 %)
3 diff
(99.6 %id)
AK025128 colon .d 1575 to 3843 1 to 2268   tiling clone, available from FLJ, AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 2268/2268
(100 %)
1 diff
(100.0 %id)
BC015697 Eye, normal, pigmented retinal epithelium .d 2411 to 3843 761 to 2193   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 1433/2193
(65 %)
0 diff
(100 %id)
CN298751 embryonic stem cells, cell lines H1, H7, andH9 .d 2795 to 3458 1 to 664       664/664
(100 %)
2 diff
(99.7 %id)
AL134416 brain .d 2814 to 3434 1 to 622       622/622
(100 %)
5 diff
(99.2 %id)
AL570565 placenta, Placenta Cot 25-normalized .d 2818 to 3815 994 to 1       994/994
(100 %)
17 diff
(98.3 %id)
BM993445 lung, Metastatic Chondrosarcoma .d 3232 to 3843 629 to 19   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 611/611
(100 %)
1 diff
(99.9 %id)
AU152833   .d 3289 to 3843 556 to 1       556/556
(100 %)
13 diff
(97.7 %id)
T50275 ovary .d 3294 to 3563 1 to 266       266/404
(65 %)
9 diff
(97.8 %id)
AI983373 brain, three pooled meningiomas .d 3338 to 3843 506 to 1       506/512
(98 %)
5 diff
(99.1 %id)
BG059858 brain, glioblastoma without EGFR amplification .d 3338 to 3846 513 to 1       513/519
(98 %)
12 diff
(97.7 %id)
BM805499 brain, hippocampus .d 3350 to 4090 224 to 972   tiling clone,   749/1175
(63 %)
21 diff
(98.3 %id)
BF223255 pooled germ cell tumors .d 3362 to 3843 482 to 1       482/482
(100 %)
1 diff
(99.8 %id)
BM709958 eye, optic nerve .d 3388 to 3632 1 to 245   fully sequenced,   245/245
(100 %)
0 diff
(100 %id)
AA091672   .d 3397 to 3680 1 to 276       276/283
(97 %)
18 diff
(93.7 %id)
BM671104 eye, optic nerve .d 3602 to 3861 260 to 1   tiling clone, fully sequenced,   260/260
(100 %)
2 diff
(99.3 %id)
AK293896 cerebellum .e 1 to 3730 1 to 3730 A117V tiling clone,   3730/3730
(100 %)
2 diff
(100.0 %id)
DC308598 cerebellum .e 1 to 583 1 to 583       583/583
(100 %)
0 diff
(100 %id)
DC309509 cerebellum .e 1 to 558 1 to 558       558/558
(100 %)
0 diff
(100 %id)
BE929917 placenta_normal .f 1 to 409 21 to 430   tiling clone,   410/430
(95 %)
1 diff
(99.8 %id)
DB163085 thymus .f 220 to 815 2 to 597   tiling clone, capped   596/596
(100 %)
0 diff
(100 %id)
CX166444 human embryonic stem cells differentiated toan early endodermal cell type .f 270 to 1137 1 to 868   tiling clone,   868/868
(100 %)
0 diff
(100 %id)
AI523629 B-cell, chronic lymphotic leukemia .f 425 to 969 570 to 26   AAA   545/725
(75 %)
18 diff
(97.6 %id)
BG998989 head_neck .f 566 to 1149 30 to 607       578/607
(95 %)
10 diff
(98.4 %id)
BI115696 lung, small cell carcinoma .f 653 to 1345 1 to 696       696/697
(99 %)
9 diff
(98.8 %id)
BF998129 placenta_normal .f 698 to 925 326 to 98       229/326
(70 %)
0 diff
(100 %id)
BF836652 head_neck .f 863 to 1187 329 to 1     Submitted on the opposite strand 329/329
(100 %)
8 diff
(97.6 %id)
BE717722 head_neck .f 919 to 1273 362 to 8       355/365
(97 %)
0 diff
(100 %id)
DB146286 thymus .f 1056 to 1622 2 to 568   tiling clone, capped   567/567
(100 %)
1 diff
(99.9 %id)
BE018974 Kidney, renal cell adenocarcinoma .f 1369 to 2002 1 to 634   tiling clone,   634/634
(100 %)
8 diff
(98.8 %id)
BE206677 Kidney, renal cell adenocarcinoma .f 3308 to 3821 514 to 1   tiling clone,   514/514
(100 %)
0 diff
(100 %id)
DA308246 hippocampus .g -8 to 577 2 to 587   tiling clone, capped   586/586
(100 %)
2 diff
(99.7 %id)
CN349289 embryonic stem cells, cell lines H1, H7, andH9 .g 83 to 738 1 to 656   tiling clone,   656/656
(100 %)
0 diff
(100 %id)
BQ344988 nervous_tumor .g 327 to 639 1 to 314       314/314
(100 %)
13 diff
(95.9 %id)
CN349290 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .h 1 to 785 9 to 792 exact tiling clone,   784/792
(98 %)
1 diff
(99.9 %id)
DA506100 brain .h 357 to 912 2 to 556   capped   555/555
(100 %)
2 diff
(99.7 %id)
DA997450   .h 453 to 1004 2 to 555   capped   554/554
(100 %)
2 diff
(99.7 %id)
BF922077 nervous_tumor .h 462 to 739 1 to 277       277/277
(100 %)
10 diff
(96.4 %id)
CN349296 embryonic stem cells, cell lines H1, H7, andH9 .h 525 to 1208 1 to 684   tiling clone,   684/684
(100 %)
0 diff
(100 %id)
DA925988 small intestine .h 600 to 1156 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
BQ320346 colon .h 637 to 1002 11 to 371       361/371
(97 %)
0 diff
(100 %id)
BQ332178 lung_tumor .h 828 to 1316 524 to 41   tiling clone,   484/524
(92 %)
9 diff
(98.3 %id)
BF924933 nervous_tumor .h 897 to 1209 320 to 8     Submitted on the opposite strand 313/320
(97 %)
12 diff
(96.3 %id)
BF926091 nervous_tumor .h 897 to 1209 320 to 8     Submitted on the opposite strand 313/320
(97 %)
12 diff
(96.3 %id)
BG110302 Bone, osteosarcoma, cell line .i 1 to 657 1 to 657 P132Q A135S Q137P P138A G139W ... tiling clone,   657/964
(68 %)
17 diff
(98.3 %id)
CN349294 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .j 1 to 608 1 to 608 exact tiling clone,   608/608
(100 %)
0 diff
(100 %id)
BQ270793 insulinoma, Pancreas .k-u 1 to 434 7 to 442       436/442
(98 %)
0 diff
(100 %id)
BQ270174 insulinoma, Pancreas .k-u 1 to 572 7 to 579   tiling clone,   573/579
(98 %)
0 diff
(100 %id)
BQ549057 insulinoma, Pancreas .k-u 1 to 530 7 to 537       531/537
(98 %)
0 diff
(100 %id)
BQ582008 insulinoma, Pancreas .k-u 1 to 547 7 to 554       548/554
(98 %)
0 diff
(100 %id)
BU789215 insulinoma, Pancreas .k-u 1 to 505 7 to 512       506/512
(98 %)
0 diff
(100 %id)
TI_149305718   .k-u 467 to 1146 771 to 92 exact tiling clone, AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 680/1020
(66 %)
4 diff
(99.7 %id)
BU686028 lung, Primary Lung Epithelial Cells .k-u 500 to 1146 665 to 19 exact AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 647/647
(100 %)
0 diff
(100 %id)
BQ548814 insulinoma, Pancreas .k-u 585 to 1161 577 to 1 exact     577/577
(100 %)
0 diff
(100 %id)
BQ581675 insulinoma, Pancreas .k-u 608 to 1161 554 to 1 exact     554/554
(100 %)
0 diff
(100 %id)
BQ267382 insulinoma, Pancreas .k-u 647 to 1161 515 to 1       515/515
(100 %)
0 diff
(100 %id)
BU788965 insulinoma, Pancreas .k-u 663 to 1161 499 to 1       499/499
(100 %)
0 diff
(100 %id)
AA776244   .k-u 725 to 1149 425 to 1       425/425
(100 %)
0 diff
(100 %id)
BE671837 pooled germ cell tumors .k-u 745 to 1146 402 to 1       402/402
(100 %)
0 diff
(100 %id)
AW294005   .k-u 796 to 1163 368 to 1       368/368
(100 %)
0 diff
(100 %id)
BU734671 eye, lens .k-u 809 to 1146 356 to 19   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 338/338
(100 %)
0 diff
(100 %id)
BG057964 dorsal root ganglia .k-u 820 to 1150 331 to 1       331/331
(100 %)
0 diff
(100 %id)
BQ022310 placenta .k-u 820 to 1163 344 to 1       344/344
(100 %)
0 diff
(100 %id)
AA683164   .k-u 833 to 1115 283 to 1       283/283
(100 %)
0 diff
(100 %id)
BI914589 brain .k-u 845 to 1146 1 to 302   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 302/302
(100 %)
0 diff
(100 %id)
BG150012 carcinoid, lung .k-u 863 to 1149 287 to 1       287/287
(100 %)
0 diff
(100 %id)
AA346411 heart .k-u 879 to 1146 268 to 1       268/268
(100 %)
0 diff
(100 %id)
AI206044 Kidney .k-u 922 to 1283 362 to 1   tiling clone,   362/362
(100 %)
0 diff
(100 %id)
BQ023892 placenta .k-u 937 to 1146 228 to 19   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 210/210
(100 %)
0 diff
(100 %id)
CA393854 eye, RPE/choroid .k-u 980 to 1146 1 to 167   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 167/167
(100 %)
0 diff
(100 %id)
AI342737 carcinoid, lung .k-u 989 to 1145 157 to 1       157/157
(100 %)
0 diff
(100 %id)
AA887390 carcinoid, lung .k-u 993 to 1145 153 to 1       153/153
(100 %)
0 diff
(100 %id)
BM888051 eye .k-u 1170 to 1520 1 to 351       351/351
(100 %)
0 diff
(100 %id)
AA363437 ovary .k-u 1179 to 1486 1 to 308       308/308
(100 %)
0 diff
(100 %id)
BE549813 carcinoid, lung .k-u 1199 to 1512 314 to 1       314/314
(100 %)
0 diff
(100 %id)
CB125323 Liver .k-u 1212 to 1767 1 to 556   tiling clone,   556/556
(100 %)
0 diff
(100 %id)
AA838609 colon, colon tumor .k-u 1239 to 1602 1 to 364       364/364
(100 %)
0 diff
(100 %id)
CN291971 embryonic stem cells, DMSO-treated H9 cellline .k-u 1279 to 1506 1 to 228       228/228
(100 %)
0 diff
(100 %id)
FN071659 breast carcinoma .k-u 1342 to 1450 1 to 109       109/109
(100 %)
0 diff
(100 %id)
AW293121   .k-u 1349 to 1513 182 to 18   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 165/165
(100 %)
0 diff
(100 %id)
AA335508 epididymis .k-u 1539 to 1854 1 to 316       316/316
(100 %)
0 diff
(100 %id)
AA384162 thyroid gland .k-u 1686 to 1946 1 to 261   tiling clone,   261/261
(100 %)
0 diff
(100 %id)
BF876143 lung_tumor .l 1 to 439 11 to 446 Y2S L3I T4Y R10E N11T ... tiling clone,   436/446
(97 %)
7 diff
(98.5 %id)
AA084097   .m-u 1 to 434 435 to 1 P93T G94M V95G P96S G99W ... tiling clone,   435/435
(100 %)
2 diff
(99.6 %id)
CN349297 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .n 1 to 797 1 to 797 exact tiling clone,   797/797
(100 %)
5 diff
(99.4 %id)
AL699216 human skeletal muscle .o 1 to 413 8 to 425 D7R G8R G9A P10S N11P ... tiling clone,   425/425
(100 %)
6 diff
(98.6 %id)
BX956039   .o 31 to 739 1 to 709 exact tiling clone,   709/709
(100 %)
1 diff
(99.9 %id)
BU662086 blood .o 43 to 735 1 to 693 exact     693/693
(100 %)
0 diff
(100 %id)
AL833124 heart .p 1 to 3220 1 to 3220 exact tiling clone, available from DKFZ, AAA Possibly primed on the genome, locally A rich (22/25 A in genome downstream of last aligned base) 3220/3220
(100 %)
4 diff
(99.9 %id)
BG707090 brain, hypothalamus .p 1811 to 2642 1 to 838   available from MGC,   838/838
(100 %)
18 diff
(97.9 %id)
BC040645 Brain, hypothalamus .p 1816 to 3221 1 to 1402   tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (22/24 A in genome downstream of last aligned base) 1402/1402
(100 %)
2 diff
(99.9 %id)
CN349295 embryonic stem cells, DMSO-treated H9 cellline .q 1 to 453 1 to 453 exact tiling clone,   453/453
(100 %)
1 diff
(99.8 %id)
DB161108 thymus .r 1 to 603 2 to 602   tiling clone, to resequence, capped   601/601
(100 %)
3 diff
(99.6 %id)
BX645398   .r 375 to 746 372 to 1   tiling clone, Submitted on the opposite strand 372/372
(100 %)
0 diff
(100 %id)
DB144542 thymus .r 498 to 1040 2 to 545 exact tiling clone, capped   544/544
(100 %)
1 diff
(99.9 %id)
DB346852 thymus .r 1692 to 2237 547 to 2   tiling clone, to resequence,   546/547
(99 %)
0 diff
(100 %id)
BE837543 prostate_normal .s-u 1 to 392 399 to 10   tiling clone,   390/402
(97 %)
0 diff
(100 %id)
BE837578 prostate_normal .s-u 1 to 404 406 to 4       403/409
(98 %)
0 diff
(100 %id)
BE837583 prostate_normal .s-u 8 to 408 1 to 400   tiling clone,   400/518
(77 %)
8 diff
(98.5 %id)
BE717713 head_neck .s-u 22 to 408 1 to 387       387/393
(98 %)
9 diff
(97.8 %id)
BE717856 head_neck .s-u 29 to 408 1 to 383       383/389
(98 %)
12 diff
(97.0 %id)
BE830376 lung_tumor .s-u 36 to 408 379 to 7       373/379
(98 %)
0 diff
(100 %id)
AI742699 pooled .s-u 94 to 615 549 to 27 T31P P32S R33P L34S D35* tiling clone, AAA Possibly primed on the genome, locally A rich (22/24 A in genome downstream of last aligned base) 523/523
(100 %)
3 diff
(99.5 %id)
DB126279 thymus .t-u 1 to 573 2 to 575 W89V F90V H91P L92P A93G ... tiling clone, capped   574/574
(100 %)
2 diff
(99.7 %id)
AI769599 2 pooled tumors (clear cell type), Kidney .u 1 to 403 403 to 3 T7H H8T L9X H13T S15X ... tiling clone,   401/412
(97 %)
4 diff
(99.1 %id)
AA975796 2 pooled tumors (clear cell type), Kidney .u 35 to 403 367 to 3   tiling clone,   365/367
(99 %)
1 diff
(99.8 %id)
AA885840 carcinoid, lung .u 233 to 395 162 to 1   tiling clone,   162/162
(100 %)
4 diff
(97.6 %id)
191 other accessions, mainly redundant or of lesser quality, also belong to this gene but are not reported.
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k-u, .l, .m-u, .n, .o, .p, .q, .r, .s-u, .t-u, .u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI